APA (7th ed.) Citation

Kobayashi, H., Looker, H. C., Satake, E., D'Addio, F., Wilson, J. M., Saulnier, P. J., . . . Krolewski, A. S. (2022). Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes. Science translational medicine, 14(657), eabj2109. https://doi.org/10.1126/scitranslmed.abj2109

Chicago Style (17th ed.) Citation

Kobayashi, Hiroki, et al. "Neuroblastoma Suppressor of Tumorigenicity 1 Is a Circulating Protein Associated with Progression to End-stage Kidney Disease in Diabetes." Science Translational Medicine 14, no. 657 (2022): eabj2109. https://doi.org/10.1126/scitranslmed.abj2109.

MLA (9th ed.) Citation

Kobayashi, Hiroki, et al. "Neuroblastoma Suppressor of Tumorigenicity 1 Is a Circulating Protein Associated with Progression to End-stage Kidney Disease in Diabetes." Science Translational Medicine, vol. 14, no. 657, 2022, p. eabj2109, https://doi.org/10.1126/scitranslmed.abj2109.